May signal gaps in post-revascularization lipid control; leaves open whether targeted strategies improve outcomes.
We evaluated the management of cardiovascular risk factors focusing on the treatment of hypercholesterolaemia in 245 patients who had had their first coronary revascularisation in a university hospital 1 year earlier.
No takes yet. Share an insight, caveat, or question.
Delacrétaz et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: